What are the active compounds in Malva sylvestris responsible for its benefits?

The primary bioactive compounds in Malva sylvestris include flavonoids such as malvidin-3-glucoside, hypolaetin, and gossypetin derivatives, along with phenolic acids like protocatechuic and p-coumaric acid. Mucilaginous polysaccharides are also key constituents, responsible for the plant's demulcent and gut-protective effects. These compounds collectively account for its antioxidant, anti-inflammatory, and potential anti-ulcerogenic properties observed in preclinical studies.

Is Malva sylvestris effective for stomach ulcers?

Preclinical evidence from rat gastric ulcer models suggests that aqueous extracts of Malva sylvestris can significantly reduce ulcer index scores, likely because its mucilaginous polysaccharides coat the gastric mucosa and limit contact with irritants. Aqueous preparations have consistently outperformed ethanolic extracts in anti-ulcerogenic assays, suggesting water-soluble compounds are the primary active fraction. However, no human clinical trials have confirmed this effect, so its use for ulcers in people remains unsupported by clinical-grade evidence.

Can Malva sylvestris interact with medications?

Yes, the high mucilage content of Malva sylvestris can form a gel-like layer in the gut that slows or reduces the absorption of orally administered drugs, a pharmacokinetic interaction similar to that seen with psyllium husk. Medications with narrow therapeutic windows, such as levothyroxine, warfarin, or certain antibiotics, are of particular concern and should be taken at least two hours apart from mallow extracts. No specific drug interaction studies have been conducted in humans, so caution is advised and consultation with a healthcare provider is recommended.

What does the research say about Malva sylvestris as an anti-inflammatory?

In vitro studies demonstrate that Malva sylvestris flavonoids and polysaccharides inhibit NF-κB activation and reduce secretion of pro-inflammatory cytokines including TNF-α and IL-6 in stimulated macrophage cell lines. Animal studies using doses of approximately 200–400 mg/kg of extract have shown reduced inflammatory markers in induced inflammation models. The evidence is limited to cell and animal studies, and no human randomized controlled trials have quantified an anti-inflammatory effect, so clinical relevance in humans is currently unknown.

How does Malva sylvestris compare to other dark leafy greens nutritionally?

Malva sylvestris provides notable amounts of vitamins A and C, calcium, and iron, along with its distinctive mucilaginous fiber and flavonoid profile that sets it apart from more common greens like spinach or kale. Its mucilage content is significantly higher than most leafy greens, giving it a unique soothing, demulcent property relevant to gut health that spinach and kale do not share. However, like many dark leafy greens, it also contains oxalates, which could contribute to kidney stone formation in susceptible individuals when consumed in large amounts.

What is the best form of Malva sylvestris supplement — dried leaf, extract, or tea?

Malva sylvestris is traditionally consumed as a tea or infusion, which allows water-soluble compounds like polysaccharides and flavonoids to extract effectively. Standardized aqueous extracts may offer more consistent dosing of active compounds, though most clinical evidence comes from animal and in vitro studies rather than human trials comparing these forms directly. Dried leaf preparations retain mucilage content that supports gastrointestinal soothing, making them functionally different from concentrated extracts despite similar active components.

Is Malva sylvestris safe for children or pregnant women?

No safety data from human clinical trials exist for Malva sylvestris use in pregnancy or pediatric populations, so use during these periods is not recommended without medical supervision. Traditional use in herbal medicine suggests tolerability, but absence of evidence is not evidence of safety in vulnerable groups. Pregnant women and caregivers should consult healthcare providers before supplementation.

Why is the evidence for Malva sylvestris benefits limited to preclinical studies?

Most research on Malva sylvestris uses animal models or laboratory (in vitro) testing rather than human clinical trials, meaning effects observed in cell cultures or rodents have not been confirmed in people. This preclinical focus is common for traditional botanical ingredients where funding for human studies is limited and regulatory pathways vary by region. Strong clinical evidence would require randomized controlled trials in human participants, which remain largely absent for this ingredient.

Malva sylvestris (Common Mallow)

Malva sylvestris (Common Mallow) is a dark leafy green rich in phenolic compounds, flavonoids such as malvidin and hypolaetin, and mucilaginous polysaccharides that drive its antioxidant and anti-inflammatory properties. These bioactives primarily act by scavenging free radicals, inhibiting pro-inflammatory cytokines, and forming a protective mucosal barrier in the gastrointestinal tract.

Category: Vegetable Evidence: 2/10 Tier: Emerging

Malva sylvestris (Common Mallow) — Hermetica Encyclopedia

Origin & History

Malva sylvestris, commonly known as common mallow, is a perennial plant native to Europe, North Africa, and Asia, belonging to the Malvaceae family. The plant grows wild in these regions and has been harvested traditionally for its leaves, flowers, and stems, which are processed into extracts using water, methanol, or other solvents. It is classified as a source of phenolic compounds, flavonoids, coumarins, and polysaccharides.

Historical & Cultural Context

Malva sylvestris has a long history in Mediterranean traditional medicine and ethnoveterinary practices for treating inflammation, gastrointestinal disturbances, skin disorders, menstrual pains, and urological issues. The plant has been used as both food and medicine across Europe, Asia, and Africa for centuries, with leaves particularly valued for anti-inflammatory and skin integrity benefits.

Health Benefits

• Antioxidant activity through phenolic compounds and flavonoids (evidence: preclinical studies only)
• Anti-inflammatory effects attributed to flavonoids and polysaccharides (evidence: in vitro and animal studies)
• Potential anti-ulcerogenic properties, with aqueous extracts showing greater effectiveness than cimetidine in animal models (evidence: preclinical only)
• Antibacterial action linked to compound Malvone A (evidence: laboratory studies)
• Wound-healing properties reported in traditional use and supported by preclinical data (evidence: animal studies)

How It Works

Flavonoids in Malva sylvestris, particularly malvidin, hypolaetin, and gossypetin glucosides, neutralize reactive oxygen species (ROS) and inhibit NF-κB signaling, thereby suppressing downstream pro-inflammatory cytokines including TNF-α and IL-6. Its mucilaginous polysaccharides form a viscous gel that physically coats gastrointestinal mucosa, reducing irritant exposure and contributing to anti-ulcerogenic effects demonstrated with aqueous extracts. Phenolic acids such as protocatechuic and p-coumaric acid further contribute to enzyme inhibition, including COX-2 suppression, reinforcing the plant's anti-inflammatory profile.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses on Malva sylvestris were identified in the available research. Evidence is limited to preclinical studies, in vitro data, animal models, and ethnobotanical reports. One preclinical study showed aqueous extracts more effective than cimetidine for anti-ulcerogenic effects in animal models, though no PMID was provided.

Clinical Summary

The evidence base for Malva sylvestris in humans remains limited, with no large-scale randomized controlled trials published as of early 2025. Antioxidant and anti-inflammatory activity has been documented primarily in in vitro cell models and rodent studies, where aqueous and ethanolic leaf extracts reduced oxidative markers and inflammatory cytokines at doses ranging from 100 to 400 mg/kg in animal models. Anti-ulcerogenic effects have been demonstrated in rat gastric ulcer models using aqueous extracts, showing statistically significant reductions in ulcer index compared to controls. Overall evidence strength is preclinical, and human efficacy and optimal dosing have not been established.

Nutritional Profile

{"macronutrients": {"protein": "3.5 g per 100 g", "fiber": "4.5 g per 100 g", "carbohydrates": "8.0 g per 100 g", "fat": "0.2 g per 100 g"}, "micronutrients": {"vitamin_C": "20 mg per 100 g", "vitamin_A": "300 IU per 100 g", "calcium": "150 mg per 100 g", "iron": "1.2 mg per 100 g", "magnesium": "45 mg per 100 g"}, "bioactive_compounds": {"phenolic_compounds": "1.5 mg per 100 g", "flavonoids": "2.0 mg per 100 g", "polysaccharides": "5.0 mg per 100 g"}, "bioavailability_notes": "The bioavailability of phenolic compounds and flavonoids may be influenced by the plant matrix and preparation methods. Cooking may reduce vitamin C content."}

Preparation & Dosage

No clinically studied dosage ranges for Malva sylvestris have been established due to lack of human clinical trials. Cosmetic formulations use concentrations up to 0.1%, but this is not based on clinical efficacy studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Chamomile, Calendula, Marshmallow root, Licorice root, Slippery elm

Safety & Interactions

Malva sylvestris is generally regarded as safe when consumed in food amounts as a culinary green, but concentrated extracts lack formal human safety trials. The plant's high mucilage content may slow gastrointestinal absorption of oral medications, potentially reducing bioavailability of drugs such as metformin or thyroid hormones if taken simultaneously. Individuals with autoimmune conditions should exercise caution given the immunomodulatory potential of its polysaccharides, and pregnant or breastfeeding women should avoid high-dose supplemental forms due to insufficient safety data. Rare hypersensitivity reactions are theoretically possible in individuals sensitive to other Malvaceae family plants.